Kezar Life Sciences earnings were -$83.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest KZR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$20.2M, down 0.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KZR reported annual earnings of -$83.7M, with -17.8% growth. The next KZR earnings date is Jun 18, 2025.
Kezar Life Sciences Earnings Reports & History FAQ
What were Kezar Life Sciences's earnings last quarter?
On KZR's earnings call on Invalid Date, Kezar Life Sciences (NASDAQ: KZR) reported Q4 2024 earnings per share (EPS) of -$2.77, up 37.61% year over year. Total KZR earnings for the quarter were -$20.22 million. In the same quarter last year, Kezar Life Sciences's earnings per share (EPS) was -$4.44.
The next KZR earnings call is Invalid Date. Add KZR to your watchlist to be reminded of Kezar Life Sciences's next earnings date.
What was KZR's earnings growth in the past year?
As of Kezar Life Sciences's earnings date in Invalid Date, Kezar Life Sciences's earnings has grown year over year. KZR earnings in the past year totalled -$83.74 million.
Is Kezar Life Sciences profitable or losing money?
As of the last Kezar Life Sciences earnings report, Kezar Life Sciences is currently losing money. Kezar Life Sciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$83.74 million, a 17.8% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.